Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Humana (HUM)

Humana Elects Robert S. Field to Board, Expanding It to Eleven Directors

Neutral Impact 2 of 5 leadership Written later

Humana's board increased its authorized directors from ten to eleven and elected Robert S. Field as a director, effective after the April 16, 2026 annual meeting. Field is a healthcare investor who will receive restricted stock units under the company's director compensation program, and the board has determined he is independent.

Key points

  • Board expanded from ten to eleven authorized directors; Field's election takes effect after the April 16, 2026 annual meeting adjourns.
  • Field is Principal and Managing Member of ηMed Capital Management LLC, an investment firm focused on U.S. healthcare services companies.
  • Field will be granted restricted stock units; no committee appointments have been determined yet.

The filing

CompanyHumana (HUM)
Form8-K, current report
Filed with the SECApr 10, 2026, 4:32 PM ET
Accession number0000049071-26-000013

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.